MASS News - Candlesense

908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook

BOSTON--(BUSINESS WIRE)-- #VipIR--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tec...

What potential risks or headwinds could cause the revised 2025 revenue outlook to fall short? Did the company provide any guidance on cash flow, capital expenditures, or balance‑sheet strength for the remainder of 2025? How does 908 Devices’ Q2 performance and 2025 guidance compare to its main competitors in the handheld chemical analysis market?

Earnings

21 days ago

908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors

BOSTON--(BUSINESS WIRE)-- #CBRN--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Dr. Brandi Vann to serve on its ...

How might this appointment affect the timeline and likelihood of upcoming product launches or regulatory approvals? What impact could these board changes have on the company's valuation multiples (e.g., P/E, EV/EBITDA) in the near term? Will the departure of Jeff George affect the company’s biopharma relationships or pipeline collaborations?

Board

22 days ago

908 Devices Appoints Christopher D. Brown to its Board of Directors

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice Presiden...

Appointments

2 months ago